Clinical Trial Update: Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating Onabotulinumtoxin A (Botox) for persistent post-stroke and vascular headache was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Migraine
• Stroke

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Alberta | Conditions: Stroke (CVA) or TIA, Headache, Migraine | Phase 1 | Status: WITHDRAWN